Sign in

CIK 0001493712

  • Non-accelerated filer
  • Smaller reporting company

Stimcell Energetics Inc.

Sign in to watch
Ticker
STME
Exchange
OTC
Industry
Surgical & Medical Instruments & Apparatus
FY end
May 31
Incorporated
NV
Entity type
Operating
EIN
383939625
Phone
+1 844-238-2692
Business address
820 - 1130 PENDER STREET, WEST, VANCOUVER, British Columbia, Canada, V6E 4A4
Former names
Cell MedX Corp., Sports Asylum, Inc., Plandel Resources, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-08-13 ARNETT JEAN M 10% owner Exercise or conversion +1,250,000 $0.05 $63K 6,250,000
2020-08-13 ARNETT JEAN M 10% owner Exercise or conversion · Stock Options (Right to Buy) +1,250,000 0
2016-09-26 ARNETT JEAN M 10% owner Other disposition · Stock Options (Right to Buy) −1,250,000 0
2016-09-26 ARNETT JEAN M 10% owner Other disposition · Stock Options (Right to Buy) −1,250,000 0
2016-09-26 ARNETT JEAN M 10% owner Other disposition · Stock Options (Right to Buy) −1,250,000 0
2016-09-26 ARNETT JEAN M 10% owner Other disposition · Stock Options (Right to Buy) −2,500,000 0
2016-09-26 ARNETT JEAN M 10% owner Other disposition · Stock Options (Right to Buy) −2,500,000 0
2014-11-25 ARNETT JEAN M VP, Corporate Strategy Grant or award · Stock Options (Right to Buy) +1,250,000 1,250,000
2014-11-25 ARNETT JEAN M VP, Corporate Strategy Grant or award · Stock Options (Right to Buy) +1,250,000 1,250,000
2014-11-25 ARNETT JEAN M VP, Corporate Strategy Grant or award · Stock Options (Right to Buy) +1,250,000 1,250,000
2014-11-25 ARNETT JEAN M VP, Corporate Strategy Grant or award · Stock Options (Right to Buy) +1,250,000 1,250,000
2014-11-25 ARNETT JEAN M VP, Corporate Strategy Grant or award · Stock Options (Right to Buy) +2,500,000 2,500,000
2014-11-25 ARNETT JEAN M VP, Corporate Strategy Grant or award · Stock Options (Right to Buy) +2,500,000 2,500,000

Page 1 of 1 · 13 trades